(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






Latest News Releases From The Newsroom

Pluristem Continues to Strengthen its Position in China and Receives Key Cell Therapy Patent

November 07th, 2016

Patent addresses methods of treating Ischemic conditions such as CLI using placental cells HAIFA, ISRAEL / CRWE PRESS RELEASE / November 07, 2016 - Pluristem Therapeutics Inc. (NasdaqCM: PSTI, TASE: PSTI ), a leading developer of placenta-based ce. Read more

Takeda to Present Broad Range of Clinical Data During 58th American Society of Hematology Annual Meeting

November 03rd, 2016

– Demonstrating Expertise and Leadership in Hematologic Oncology, Presentations Include Phase 3 Data on ADCETRIS® (brentuximab vedotin) in CD30-Positive Cutaneous T-Cell Lymphoma, NINLARO™ (ixazomib) in Relapsed/Refractory Multiple My. Read more

Bombardier to report Third Quarter 2016 Financial Results on November 10, 2016

November 03rd, 2016

Montréal, Québec / CRWE PRESS RELEASE / November 3, 2016 - Bombardier (TSX: BBD.A)(TSX: BBD.B)(OTCQX:BDRBF) will publish its financial results for the third quarter of 2016 on Thursday, November 10, 2016, and will hold a live webcast/co. Read more

Aurinia Announces Plans for Single Phase III Clinical Trial for Voclosporin in the Treatment of Lupus Nephritis Following Successful Completion of End of Phase II Meeting With FDA

November 02nd, 2016

-Voclosporin 23.7mg BID to advance into double-blind placebo controlled Phase III study -AURORA Phase III study design consistent with AURA -Trial expected to commence in Q2 2017 -Conference Call and webcast at 8:30am ET tomorrow Victoria. Read more

CP disappointed with TSB Chair's misguided statements regarding latest Watchlist

November 01st, 2016

Calgary, AB / CRWE PRESS RELEASE / November 1, 2016 - Canadian Pacific (TSX: CP) (NYSE: CP) is disappointed in the Transportation Safety Board's (TSB) misguided comments on the topic of fatigue in the railway industry, which do little to enhance . Read more

Bombardier Business Aircraft Kicks Off NBAA with Solid Order and Delivery Performance

November 01st, 2016

Montréal, Québec / CRWE PRESS RELEASE / November 1, 2016 - Bombardier Business Aircraft today announced strong order and delivery performance during the three months ending September 30, 2016. The announcement was made at the annual Nat. Read more

BlackBerry Signs Agreement with Ford Motor Company for Expanded Use of BlackBerry's QNX and Security Software

October 31st, 2016

Deal signifies acceleration in the Company’s pivot from hardware to software and extends its position in the automotive sector where security and mobility are critical for the connected car Waterloo, ON / CRWE PRESS RELEASE / Oct. . Read more

Bombardier C Series Aircraft Makes Its China Debut

October 30th, 2016

Montréal, Québec / CRWE PRESS RELEASE / October 30, 2016 - Bombardier Commercial Aircraft announced today that its CS300 jetliner, the second CS300 flight test vehicle, has arrived in Zhuhai, China. The visit is the debut. Read more

Zetta Jet Diversifies its Fleet with Four Bombardier Challenger 650 Business Jets Through Financing Agreement with Minsheng Financial Leasing

October 30th, 2016

The first Challenger aircraft to join Zetta Jet’s fleet of Global business jets Challenger 650 aircraft delivers the widest cabin and only true 12-passenger capability in its class Orlando, Florida / CRWE PRESS RELEASE / Oct. Read more

GE and Baker Hughes to Host Investor Webcast Monday October 31 at 8:30 AM ET

October 30th, 2016

Boston / CRWE PRESS RELEASE / October 30, 2016 - GE and Baker Hughes will host an Investor webcast at 8:30 am ET/5:30 am PT on October 31, 2016. The webcast and accompanying slides can be accessed on our investor website www.GE.com/inv. Read more